These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2191317)

  • 1. Plasma exchange in transplant rejection.
    Vangelista A; Frascà GM; Liviano-D'Arcangelo G; Mosconi G; Bonomini V
    Prog Clin Biol Res; 1990; 337():253-5. PubMed ID: 2191317
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma exchange in acute renal transplant rejection.
    Blake P; Sutton D; Cardella CJ
    Prog Clin Biol Res; 1990; 337():249-52. PubMed ID: 2191316
    [No Abstract]   [Full Text] [Related]  

  • 3. Antithymocyte globulin as the primary treatment for renal allograft rejection.
    Nelson PW; Cosimi AB; Delmonico FL; Rubin RH; Tolkoff-Rubin NE; Fang L; Russell PS
    Transplantation; 1983 Nov; 36(5):587-9. PubMed ID: 6356523
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma exchange conditioning for ABO-incompatible renal transplantation.
    Winters JL; Gloor JM; Pineda AA; Stegall MD; Moore SB
    J Clin Apher; 2004; 19(2):79-85. PubMed ID: 15274200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uses of antilymphocyte globulin in renal transplantation.
    Novick AC
    Urol Clin North Am; 1983 May; 10(2):253-62. PubMed ID: 6344386
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of antilymphocyte induction therapy in liver transplantation.
    Wall WJ
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S64-70. PubMed ID: 10431019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
    Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR
    Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of three immunosuppressive regimens in high-risk patients: immunologic aspects.
    Renna Molajoni E; Bachetoni A; Cinti P; Sallustio F; Rossi M; Pretagostini R; Orlandini A; Berloco P; Alfani D; Cortesini R
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1978-80. PubMed ID: 3079064
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum erythropoietin and parathyroid hormone concentrations in kidney transplant patients during acute graft rejection.
    Kokot F; Wiecek A; Grzeszczak W; Lao M; Kuśmierski S; Cierpka L; Gradowska L; Jagiełło R
    Transplant Proc; 1996 Dec; 28(6):3477-9. PubMed ID: 8962352
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of acute rejection with antithymocyte globulin (Thymoglobuline): its potential to reduce corticosteroids.
    Cantarovich D
    J Nephrol; 2004; 17 Suppl 8():S40-6. PubMed ID: 15599885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal allograft and intensive plasma exchange: a critical assessment.
    Cardella CJ
    Prog Clin Biol Res; 1982; 106():283-90. PubMed ID: 6757945
    [No Abstract]   [Full Text] [Related]  

  • 12. Early glomerular rejection in sensitized patients: treatment with plasma exchange and antithymocyte globulin.
    Faull RJ; Russ GR; Nicholls C; Mathew TH
    Transplant Proc; 1988 Feb; 20(1):14-6. PubMed ID: 3278457
    [No Abstract]   [Full Text] [Related]  

  • 13. Antilymphocyte globulin for the treatment of steroid non-responsive acute renal allograft rejection.
    Griffin PJ; Williams GT; Salaman JR
    Clin Nephrol; 1984 Feb; 21(2):115-7. PubMed ID: 6373078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathology of canine renal allografts prolonged by sheep antilymphocyte plasma.
    Fox M; Diethelm AG; Glassock RJ; Orr WM; Dubernard JM; Stuart FP; Dammin GJ; Murray JE
    Invest Urol; 1971 Mar; 8(5):563-74. PubMed ID: 4104119
    [No Abstract]   [Full Text] [Related]  

  • 15. [Renal transplant and chronic rejection in pediatrics].
    Cano FJ
    Rev Med Chil; 1998 Jan; 126(1):96-106. PubMed ID: 9629760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney transplantation from donors without a heartbeat.
    Luan FL
    N Engl J Med; 2002 Nov; 347(22):1799-801; author reply 1799-801. PubMed ID: 12462226
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of steroid-resistant rejections with ATG and/or plasma filtration improves graft survival rates after cadaveric kidney transplantation.
    Fassbinder W; Bechstein PB; Stutte HJ; Scheuermann EH; Hanke P; Knöner M; Dathe G; Jonas D; Schoeppe W
    Neth J Med; 1985; 28(6):265-7. PubMed ID: 3892329
    [No Abstract]   [Full Text] [Related]  

  • 18. Brequinar sodium significantly reduces the incidence of steroid-resistant rejection and resource utilization in primary renal transplant patients compared with azathioprine.
    Dunn JF; Hatch J; Precht A; Hart M; Li S
    Transplant Proc; 1996 Apr; 28(2):955-7. PubMed ID: 8623479
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of plasmapheresis in kidney transplantation--a controlled study].
    Vangelista A; Frascà GM; di Felice A; Liviano d'Arcangelo G; Bonomini V
    Z Urol Nephrol; 1986 Jun; 79(6):311-6. PubMed ID: 3529744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft mucormycosis in a renal allograft recipient.
    Ahmad M
    J Nephrol; 2005; 18(6):783-6. PubMed ID: 16358241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.